AnesthesiaDermatophytesDiagnostic radiologyEmergency MedicineFamily MedicineInternal MedicineMedical GeneticsNeurologyNuclear drugsObstetrics and GynecologyOphthalmologyPediatricsPhysical Medicine & RehabilitationUncategorized

Persuasion is often more effectual than force

Persuasion is often more effectual than force

The mission of the Advanced Liver Diseases Study Group is to become the premier epidemiology, clinical,

translational research, and treatment center for advanced liver diseases, cirrhosis, and portal hypertension in the

world. Additionally, the mission is to mentor and educate clinician investigators in the field of hepatology.


Please Take Attention, This

is just a Dummy Content,

Not a real facts about


The group is part of the Hepatic Vascular Cell

Signaling Lab and Hepatocellular Carcinoma Lab

programs as a major initiative involves collaboration

with scientists to establish translational research.The

activities of the Advanced Liver Diseases Study

Group span from population-based research that utilizes the extensive resources of the Rochester

Carcinoma Lab programs

  1. Understand the molecular and physiological mechanisms involved in cirrhosis and portal hypertension.
  2. Understand the mechanisms that underlie cirrhosis and portal hypertension by integrating basic science and
    clinical research programs.
  3. Develop and validate non-invasive diagnostic tools to evaluate and quantitate severity of liver fibrosis and portal hypertension.

Persuasion is often more effectual than force


It is with truly mixed emotions that I announce the

departure of Philip E. Bourne, Ph.D., who will be

leaving his post as NIH’s first Associate Director for

Data Science to become the Stephenson Chair of Data Science, Director of the Data Science Institute, and

Professor in the Department of Biomedical Engineering at the University of Virginia, Charlottesville.  I am happy

for Phil to have this exceptional opportunity, and know that UVA will be well served by his depth of knowledge in

data science.  At the same time, I am saddened that NIH will be losing his prowess and passion for tackling the

opportunities and challenges of our increasingly data-driven biomedical research enterprise.


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button